NeuroSense Granted Patents in Europe, Japan, and Israel for its ALS Drug PrimeC

Patents valid through 2038 Clinical topline results from Phase 2b ALS trial expected in H2 2023 Corresponding patents have b...

September 21, 2023 | Thursday | News
AHF Slams Johnson & Johnson for Immoral Profiteering on TB Treatment

“While shocking, this move by Johnson & Johnson is unfortunately not surprising – we demand that the company halt its profiteering tactics ...

September 20, 2023 | Wednesday | News
Revolutionizing Hyperbaric Oxygen Therapy: BARIKS Unveils Game-Changing Portable Chambers

In an exclusive interview with Yoav Blat, BARIKS' Representative in North America, we explore the technology behind this chamber and its potential to revol...

September 11, 2023 | Monday | News
Clearmind Medicine Collaborates with Johns Hopkins to Study CMND-100 for Alcohol Use Disorder

The principal investigator, Jennifer Ellis, PhD, Associate Professor of Psychiatry and Behavioral Sciences, JHU School of Medicine will be supported by co-...

September 07, 2023 | Thursday | News
MediWound Announces Collaboration with Mölnlycke on EscharEx® Phase III Study

MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today anno...

August 16, 2023 | Wednesday | News
Hikma & Rakuten Medical License Alluminox™ Cancer Treatment for MENA

Under the terms of the agreement, Hikma has an exclusive license to commercialise products in Rakuten Medical’s pipeline using its photoimmunotherapy...

August 14, 2023 | Monday | News
Impact Biotech Collaborates to Develop Pathologic Myopia Treatment with Padeliporfin Platform

ImPact Biotech, a leader in photodynamic therapy, recently announced an agreement with Maastricht University to collaborate in research focused on eye...

August 14, 2023 | Monday | News
PAN-TB Begins Phase 2 Trial for New TB Treatments

The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration announced today the start of a phase 2b/c clinical trial, sponsored by the...

August 10, 2023 | Thursday | News
ImPact Biotech Gets FDA Clearance for Padeliporfin VTP Phase 1 in Lung Cancer

 ImPact Biotech, the IMmune Photo Activated Cancer Treatment (IMPACT) specialist announces the U.S. Food and Drug Administrat...

August 07, 2023 | Monday | News
Teva Pharmaceuticals and Alvotech Share Update on Biosimilars Partnership

The partners continue working closely on matters concerning pending approval in the U.S. for AVT02, an interchangeable high-concentration biosimilar candid...

July 25, 2023 | Tuesday | News
Corning Collaborates with Laurus Labs on G4 Reactor Installation

Corning Incorporated and Laurus Labs recently celebrated the installation of Corning® Advanced-Flow™ Reactors (AFR) G4 unit a...

July 19, 2023 | Wednesday | News
Examining the Biopharma Industry's Declining Resilience: Factors, Vulnerabilities, and Strategies for Growth

Join us for an in-depth conversation with Chua Keng Hock as we explore the challenges, strategies, and future prospects of the biopharma industry in today'...

July 18, 2023 | Tuesday | Interaction
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder

SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat...

July 17, 2023 | Monday | News
Merck Invests € 23 Million to Expand Cell Culture Media Production in Kansas, USA

Lenexa, Kansas, USA facility becomes company’s largest dry powder cell culture media facility and Center of Excellence  in North America Boos...

July 13, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in